CVEvulnerability

CVE-2026-93997

5.5 MEDIUM Published 2026-09-20 Modified 2026-09-21 Official page ↗
Status
Deferred
Published
2026-09-20
Last modified
2026-09-21
Assigner
[email protected]
CVSS 4.0 ([email protected])
5.5 MEDIUM — CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
CVSS 3.1 ([email protected])
7.3 HIGH — CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L
CVSS 2.0 ([email protected])
7.5 HIGH — AV:N/AC:L/Au:N/C:P/I:P/A:P
Weaknesses
CWE-74, CWE-89

Description

A weakness has been identified in SourceCodester Drug Recommendation System 1.0. Affected by this issue is some unknown functionality of the file /Admin/edit_symptom.php. This manipulation of the argument ID causes sql injection. The attack is possible to be carried out remotely. The exploit has been made available to the public and could be used for attacks.

Related

Weakness · CWE (2)

  • CWE-74 Improper Neutralization of Special Elements in Output Used by a Downstream Component weakness
  • CWE-89 Improper Neutralization of Special Elements used in an SQL Command weakness

References